INS and diabetes mellitus: But despite the relative success of subcutaneously administered basal/bolus insulin dosage regimens in controlling glycaemic levels, significant challenges remain to optimise the effective treatment of diabetes worldwide, such as improving glycaemic control, increasing therapeutic compliance, mitigating weight gain and enhancing the overall quality of life for patients.1